NRx Pharmaceuticals, Inc. (NRXPW)

NASDAQ: NRXPW · Real-Time Price · USD · Warrants
0.0900
+0.0200 (28.57%)
Nov 28, 2025, 4:00 PM EST - Market closed
28.57%
Market Cap68.84M
Revenue (ttm)242,000
Net Income (ttm)-38.06M
Shares Out 28.10M
EPS (ttm)-2.21
PE Ration/a
Forward PE19.12
Dividendn/a
Ex-Dividend Daten/a
Volume7,409
Open0.1000
Previous Close0.0700
Day's Range0.0727 - 0.1000
52-Week Range0.0500 - 0.5000
Beta1.90
Analystsn/a
Price Targetn/a
Earnings Daten/a

About NRXPW

NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain. Its lead drug candidates include NRX-101, an oral, fixed dosed combination of D-cycloserine and lurasidone for suicidal treatment-resistant bipolar depression in patients with sub-acute suicidal ideation and behavior in phase 2 trial; and NRX-100, a preservative-free formulation of ketamine for intravenous infusi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country United States
Stock Exchange NASDAQ
Ticker Symbol NRXPW
Full Company Profile

News

There is no news available yet.